Ameriprise Financial Inc has a consensus price target of $421.86 based on the ratings of 15 analysts. The high is $504 issued by Jefferies on June 28, 2024. The low is $310 issued by Morgan Stanley on November 18, 2021. The 3 most-recent analyst ratings were released by UBS, Keefe, Bruyette & Woods, and Jefferies on July 9, 2024, July 8, 2024, and June 28, 2024, respectively. With an average price target of $489.67 between UBS, Keefe, Bruyette & Woods, and Jefferies, there's an implied 11.40% upside for Ameriprise Financial Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/09/2024 | Buy Now | 12.62% | UBS | Brennan Hawken | $500 → $495 | Maintains | Buy | Get Alert |
07/08/2024 | Buy Now | 6.93% | Keefe, Bruyette & Woods | Ryan Krueger | $460 → $470 | Maintains | Market Perform | Get Alert |
06/28/2024 | Buy Now | 14.67% | Jefferies | Suneet Kamath | $500 → $504 | Maintains | Buy | Get Alert |
06/28/2024 | Buy Now | -11.95% | Piper Sandler | John Barnidge | $390 → $387 | Maintains | Underweight | Get Alert |
05/06/2024 | Buy Now | 4.65% | Argus Research | Kevin Heal | $440 → $460 | Maintains | Buy | Get Alert |
04/24/2024 | Buy Now | 9.21% | RBC Capital | Kenneth Lee | $470 → $480 | Maintains | Outperform | Get Alert |
04/11/2024 | Buy Now | 1.24% | Evercore ISI Group | Thomas Gallagher | $400 → $445 | Maintains | In-Line | Get Alert |
04/10/2024 | Buy Now | 4.65% | Keefe, Bruyette & Woods | Ryan Krueger | $420 → $460 | Maintains | Market Perform | Get Alert |
04/09/2024 | Buy Now | -0.58% | Morgan Stanley | Michael Cyprys | $400 → $437 | Maintains | Equal-Weight | Get Alert |
04/05/2024 | Buy Now | -10.82% | Piper Sandler | John Barnidge | $360 → $392 | Maintains | Underweight | Get Alert |
03/27/2024 | Buy Now | 11.03% | Goldman Sachs | Alexander Blostein | $437 → $488 | Maintains | Buy | Get Alert |
03/21/2024 | Buy Now | — | Raymond James | Wilma Burdis | — | Initiates | → Market Perform | Get Alert |
01/30/2024 | Buy Now | -4.45% | Keefe, Bruyette & Woods | Ryan Krueger | $400 → $420 | Maintains | Market Perform | Get Alert |
01/29/2024 | Buy Now | -9% | Morgan Stanley | Michael Cyprys | $394 → $400 | Maintains | Equal-Weight | Get Alert |
01/26/2024 | Buy Now | 2.38% | RBC Capital | Kenneth Lee | $420 → $450 | Maintains | Outperform | Get Alert |
01/25/2024 | Buy Now | 1.24% | UBS | Brennan Hawken | $440 → $445 | Maintains | Buy | Get Alert |
01/22/2024 | Buy Now | -4.45% | RBC Capital | Kenneth Lee | $410 → $420 | Maintains | Outperform | Get Alert |
01/09/2024 | Buy Now | 0.1% | UBS | Brennan Hawken | $375 → $440 | Maintains | Buy | Get Alert |
01/04/2024 | Buy Now | -9% | Evercore ISI Group | Thomas Gallagher | $385 → $400 | Downgrade | Outperform → In-Line | Get Alert |
01/03/2024 | Buy Now | 2.83% | Goldman Sachs | Alexander Blostein | → $452 | Upgrade | Neutral → Buy | Get Alert |
12/22/2023 | Buy Now | -12.86% | Morgan Stanley | Michael Cyprys | $365 → $383 | Assumes | → Equal-Weight | Get Alert |
11/15/2023 | Buy Now | -16.96% | Morgan Stanley | Nigel Dally | $360 → $365 | Maintains | Equal-Weight | Get Alert |
10/31/2023 | Buy Now | -6.72% | RBC Capital | Kenneth Lee | → $410 | Reiterates | Outperform → Outperform | Get Alert |
08/18/2023 | Buy Now | -18.1% | Morgan Stanley | Nigel Dally | $350 → $360 | Maintains | Equal-Weight | Get Alert |
08/02/2023 | Buy Now | -20.37% | Morgan Stanley | Nigel Dally | $350 → $350 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
08/01/2023 | Buy Now | -6.72% | RBC Capital | Kenneth Lee | $385 → $410 | Maintains | Outperform | Get Alert |
07/27/2023 | Buy Now | -20.37% | Morgan Stanley | Nigel Dally | $340 → $350 | Maintains | Equal-Weight | Get Alert |
06/09/2023 | Buy Now | -20.37% | Keefe, Bruyette & Woods | Ryan Krueger | $360 → $350 | Maintains | Market Perform | Get Alert |
06/02/2023 | Buy Now | -22.65% | Morgan Stanley | Nigel Dally | $338 → $340 | Maintains | Equal-Weight | Get Alert |
04/27/2023 | Buy Now | -12.41% | RBC Capital | Kenneth Lee | $400 → $385 | Maintains | Outperform | Get Alert |
04/12/2023 | Buy Now | -23.1% | Morgan Stanley | Nigel Dally | $360 → $338 | Maintains | Equal-Weight | Get Alert |
02/01/2023 | Buy Now | -8.77% | Credit Suisse | Andrew Kligerman | $382 → $401 | Maintains | Outperform | Get Alert |
01/31/2023 | Buy Now | -14.68% | Keefe, Bruyette & Woods | Ryan Krueger | $350 → $375 | Maintains | Market Perform | Get Alert |
01/10/2023 | Buy Now | -21.51% | Morgan Stanley | Nigel Dally | $340 → $345 | Maintains | Equal-Weight | Get Alert |
01/09/2023 | Buy Now | -15.82% | UBS | Brennan Hawken | $355 → $370 | Maintains | Buy | Get Alert |
12/19/2022 | Buy Now | -26.06% | Keefe, Bruyette & Woods | Ryan Krueger | → $325 | Downgrade | Outperform → Market Perform | Get Alert |
11/23/2022 | Buy Now | -24.92% | Goldman Sachs | Alexander Blostein | $290 → $330 | Maintains | Neutral | Get Alert |
11/17/2022 | Buy Now | -22.65% | Morgan Stanley | Nigel Dally | $310 → $340 | Maintains | Equal-Weight | Get Alert |
10/28/2022 | Buy Now | -20.37% | RBC Capital | Kenneth Lee | $310 → $350 | Maintains | Outperform | Get Alert |
10/26/2022 | Buy Now | -29.47% | Morgan Stanley | Nigel Dally | $295 → $310 | Maintains | Equal-Weight | Get Alert |
10/07/2022 | Buy Now | -43.12% | Piper Sandler | John Barnidge | $240 → $250 | Maintains | Underweight | Get Alert |
09/07/2022 | Buy Now | -23.56% | B of A Securities | Craig Siegenthaler | → $336 | Initiates | → Buy | Get Alert |
08/17/2022 | Buy Now | -32.88% | Morgan Stanley | Nigel Dally | $270 → $295 | Maintains | Equal-Weight | Get Alert |
07/27/2022 | Buy Now | -38.57% | Morgan Stanley | Nigel Dally | $255 → $270 | Maintains | Equal-Weight | Get Alert |
07/15/2022 | Buy Now | -49.95% | Piper Sandler | John Barnidge | $231 → $220 | Maintains | Underweight | Get Alert |
07/08/2022 | Buy Now | -47.45% | Piper Sandler | John Barnidge | $253 → $231 | Maintains | Underweight | Get Alert |
07/06/2022 | Buy Now | -27.2% | Evercore ISI Group | Thomas Gallagher | $364 → $320 | Maintains | Outperform | Get Alert |
07/06/2022 | Buy Now | -41.98% | Morgan Stanley | Nigel Dally | $330 → $255 | Maintains | Equal-Weight | Get Alert |
06/24/2022 | Buy Now | -38.57% | Goldman Sachs | Alexander Blostein | $325 → $270 | Downgrade | Buy → Neutral | Get Alert |
06/16/2022 | Buy Now | -42.44% | Piper Sandler | John Barnidge | $275 → $253 | Maintains | Underweight | Get Alert |
05/27/2022 | Buy Now | -37.43% | Piper Sandler | John Barnidge | $285 → $275 | Maintains | Underweight | Get Alert |
04/28/2022 | Buy Now | -20.37% | RBC Capital | Kenneth Lee | $360 → $350 | Maintains | Outperform | Get Alert |
04/26/2022 | Buy Now | -20.37% | UBS | Brennan Hawken | $360 → $350 | Maintains | Buy | Get Alert |
04/26/2022 | Buy Now | -24.92% | Morgan Stanley | Nigel Dally | $335 → $330 | Maintains | Equal-Weight | Get Alert |
04/08/2022 | Buy Now | -23.78% | Morgan Stanley | Nigel Dally | $338 → $335 | Maintains | Equal-Weight | Get Alert |
04/06/2022 | Buy Now | -29.47% | Piper Sandler | John Barnidge | $325 → $310 | Downgrade | Neutral → Underweight | Get Alert |
04/04/2022 | Buy Now | -20.37% | Jefferies | Suneet Kamath | $325 → $350 | Maintains | Buy | Get Alert |
03/01/2022 | Buy Now | -26.06% | Piper Sandler | John Barnidge | $370 → $325 | Downgrade | Overweight → Neutral | Get Alert |
02/22/2022 | Buy Now | -23.1% | Morgan Stanley | Nigel Dally | $325 → $338 | Maintains | Equal-Weight | Get Alert |
01/27/2022 | Buy Now | -26.06% | Morgan Stanley | Nigel Dally | $320 → $325 | Maintains | Equal-Weight | Get Alert |
01/26/2022 | Buy Now | -19.23% | Jefferies | Suneet Kamath | → $355 | Initiates | → Buy | Get Alert |
01/07/2022 | Buy Now | -27.2% | Morgan Stanley | Nigel Dally | $310 → $320 | Maintains | Equal-Weight | Get Alert |
01/05/2022 | Buy Now | -17.64% | Evercore ISI Group | Thomas Gallagher | $305 → $362 | Upgrade | In-Line → Outperform | Get Alert |
01/04/2022 | Buy Now | -16.96% | UBS | Brennan Hawken | $355 → $365 | Maintains | Buy | Get Alert |
01/04/2022 | Buy Now | -12.41% | Goldman Sachs | Alexander Blostein | $350 → $385 | Maintains | Buy | Get Alert |
11/18/2021 | Buy Now | -29.47% | Morgan Stanley | — | — | Maintains | Equal-Weight | Get Alert |
11/02/2021 | Buy Now | -20.83% | Credit Suisse | Andrew Kligerman | — | Maintains | Outperform | Get Alert |
10/29/2021 | Buy Now | -20.37% | RBC Capital | Kenneth Lee | — | Maintains | Outperform | Get Alert |
10/27/2021 | Buy Now | -30.61% | Morgan Stanley | Nigel Dally | — | Maintains | Equal-Weight | Get Alert |
10/14/2021 | Buy Now | -35.16% | Morgan Stanley | Nigel Dally | — | Maintains | Equal-Weight | Get Alert |
10/12/2021 | Buy Now | -25.38% | Wolfe Research | Steven Chubak | — | Initiates | → Outperform | Get Alert |
07/27/2021 | Buy Now | -39.71% | Morgan Stanley | Nigel Dally | — | Maintains | Equal-Weight | Get Alert |
The latest price target for Ameriprise Finl (NYSE:AMP) was reported by UBS on July 9, 2024. The analyst firm set a price target for $495.00 expecting AMP to rise to within 12 months (a possible 12.62% upside). 26 analyst firms have reported ratings in the last year.
The latest analyst rating for Ameriprise Finl (NYSE:AMP) was provided by UBS, and Ameriprise Finl maintained their buy rating.
The last upgrade for Ameriprise Financial Inc happened on January 3, 2024 when Goldman Sachs raised their price target to $452. Goldman Sachs previously had a neutral for Ameriprise Financial Inc.
The last downgrade for Ameriprise Financial Inc happened on January 4, 2024 when Evercore ISI Group changed their price target from $385 to $400 for Ameriprise Financial Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ameriprise Finl, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ameriprise Finl was filed on July 9, 2024 so you should expect the next rating to be made available sometime around July 9, 2025.
While ratings are subjective and will change, the latest Ameriprise Finl (AMP) rating was a maintained with a price target of $500.00 to $495.00. The current price Ameriprise Finl (AMP) is trading at is $439.54, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.